Dr Reddy’s Laboratories share price slips 0.58% to ₹1,377 on November 11
Last Updated: 11th November 2026 - 05:16 pm
Key Takeaways
- Dr Reddy’s closed at ₹1,377, down ₹8 or 0.58%, after moving between ₹1,372 and ₹1,399.
- The closing price stayed more than ₹110 above each of its 50-day, 100-day and 200-day DMAs.
- Returns remained positive across one month, three months, six months and one year, led by an 18.83% three-month reading.
Dr Reddy’s Laboratories share price finished November 11 at ₹1,377, down ₹8 or 0.58%. The share opened at ₹1,399 against a previous close of ₹1,385. It also reached ₹1,399 at the session high before falling as low as ₹1,372. The ₹27 intraday range left the closing price ₹22 below the high and ₹5 above the low.
Volume reached 1,742,767 shares. The stock remained above each of its principal moving-average levels despite the daily decline. The 50-day DMA was ₹1,264.10, leaving the close ₹112.90 higher. The 100-day and 200-day DMAs were particularly close to each other at ₹1,246.60 and ₹1,246.20. Dr Reddy’s closed about ₹131 above both.
The displayed 52-week range ran from ₹1,101 to ₹1,415. November 11 ended only ₹38 below the annual high and ₹276 above the low. The session high of ₹1,399 was itself only ₹16 short of the displayed 52-week high.
Unlike several other constituents, the stock's return readings were positive across every available period. The one-month return stood at 15.04%, the three-month figure at 18.83%, the six-month return at 6.42%, and one-year performance at 14.87%. The strongest of these was the three-month reading, while the six-month figure was the lowest. The difference between them was 12.41 percentage points. The November 11 decline therefore occurred while each displayed historical return period remained above zero.
Frequently Asked Questions
What was the Dr Reddy’s Laboratories share price on November 11?
How close was Dr Reddy’s to its 52-week high?
What were Dr Reddy’s recent returns?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.